AMGN

3 Healthcare Giants Just Raised Dividends—Here’s Who Pays the Most

12/16 01:11 pm

Should You Buy the 5 Highest-Paying Dividend Stocks in the Dow Jones Before 2026?

12/16 01:07 pm

Here's How Many Shares of SCHD You'd Need for $1,000 in Yearly Dividends

12/16 08:17 am

Argenx Halts Phase 3 Thyroid Eye Disease Trial, Peers Like Viridian Therapeutics To Benefit

12/15 11:25 am

Want Decades of Passive Income? Buy This Index Fund and Hold It Forever.

12/14 06:15 am

FDA Approves Amgen’s UPLIZNA® (inebilizumab-cdon) for Generalized Myasthenia Gravis (gMG), Expanding Treatment Options for Patients Living with Autoimmune Neuromuscular Disease

12/12 01:43 pm

FDA Approves Amgen's Drug For Rare Muscle Disorder

12/12 12:30 pm

Prolynx Secures $70 Million Series A to Advance Portfolio of Ultra-Long-Acting Obesity Candidates and Appoints Chris Boulton as Chief Executive Officer

12/11 08:00 am

AMGEN ANNOUNCES 2026 FIRST QUARTER DIVIDEND

12/09 05:01 pm

Peptide Therapeutics Market Size to Reach USD 82.19 Billion by 2032; Surging Requirements for Targeted Medicines in Oncology Augment Market Expansion - SNS Insider

12/06 10:10 am

3 Top ETFs I Plan to Pile Into in December to Boost My Passive Income in 2026

12/04 07:15 am

Should You Buy This Biotech Stock That Just Gained 5% in 1 Day?

12/01 12:15 am

Teva erhält Zulassung der Europäischen Kommission für PONLIMSI® (Denosumab), ein Biosimilar zu Prolia®, und DEGEVMA® (Denosumab), ein Biosimilar zu Xgeva®

11/25 08:06 pm

Teva obtient les autorisations de la Commission européenne pour PONLIMSI® (dénosumab), biosimilaire de Prolia® et DEGEVMA® (dénosumab), biosimilaire de Xgeva®

11/25 08:06 pm

Hospital Care Collaboration and Licensing Agreements Analysis Report and Directory 2025: Upfront, Milestone, and Royalties for 726 Deals by Company A-Z, Therapy Focus and Technology Type

11/19 11:59 am

Metabolic Collaboration and Licensing Agreements Analysis Report and Directory 2025: Upfront, Milestone, and Royalties for 576 Deals by Company A-Z, Therapy Focus and Technology Type

11/19 11:58 am

Tech Stocks Drop, Pharma Gains As Sector Rotation Picks Up: What's Moving Markets Tuesday?

11/18 02:15 pm

This Sector Is Suddenly Crushing the Broader Market. Should You Invest $1,000?

11/17 06:25 am

CytomX Therapeutics to Present at the Jefferies London Healthcare Conference

11/13 09:00 am

Is the Schwab U.S. Dividend Equity ETF the "Ultimate Retirement Fund" for Investors?

11/13 05:08 am

Why Amgen Stock Was a Nearly 5% Winner Today

11/11 06:31 pm

New to Investing? These Are 2 Excellent ETFs to Put in Your Portfolio for Years.

11/10 07:37 am

Is the Schwab U.S. Dividend Equity ETF a Buy Now?

11/08 09:31 am

Amgen Stock Momentum Builds as Institutions Return to Buying Mode

11/07 03:03 pm

Arvind Sood joins Coherus Oncology as Chief Strategy and Corporate Affairs Officer

11/06 02:54 pm

High Concentration mAb Products Market Advancing Precision Biopharmaceutical Therapeutics – Towards Healthcare

11/06 12:00 pm

Why Amgen Stock Was Crushing It on Wednesday

11/05 03:26 pm

Schwab U.S. Dividend Equity ETF (SCHD) Offers Higher Yield and Lower Fees Than ProShares S&P 500 Dividend Aristocrats ETF (NOBL)

11/04 12:01 pm

AMGEN ANNOUNCES 2025 FOURTH QUARTER DIVIDEND

10/31 04:01 pm

Kuick Research Highlights Explosive Growth and M&A Momentum In Global Multispecific Antibody Market

10/31 06:01 am

CytomX Therapeutics to Report Third Quarter 2025 Financial Results on November 6, 2025

10/30 08:00 am

Small Cell Lung Cancer Market Research 2025-2035: Growth Driven by Advancements in Novel Therapies, Including Immunotherapies, Targeted Therapies, and Combination Treatments

10/21 04:41 am

Weight Loss Drugs Market Set to Reach USD 50.26 Billion by 2032, Driven by Prescription Drug Adoption and Breakthrough Formulations – SNS Insider

10/20 09:00 am

3 Dividend-Paying ETFs to Double Down On Even if the S&P 500 Sells Off in October

10/20 08:21 am

CD40 Targeting Therapy Clinical Trials Anti CD40 Antibody Therapy Market Opportunity Assessment Insight

10/14 01:52 pm

OX40 Targeted Therapy Clinical Trials Anti OX40 Antibody Development Market Opportunity Insight 2026

10/14 01:46 pm

The Best Dividend ETF to Invest $1,000 in Right Now

10/12 01:05 pm

Gene Therapy Market Size to Worth USD 58.87 Billion Rising at 20% CAGR by 2034 | Towards Healthcare

10/08 10:00 am

Destiny Wealth Sells $8.1 Million in IBB Shares — Here’s Why Biotech Stocks Are Lagging

10/07 02:23 pm

Martin Capital Dumps $3.0 Million Worth of LyondellBasell Industries Stock

10/06 02:03 pm

Martin Capital Sells $3.6 Million in JPMorgan Stock — What to Know Ahead of Q3 Earnings

10/06 10:33 am

2 High-Yield Dividend Growth Stocks to Buy in October and Hold for a Decade or Longer

10/02 03:26 am

Immatics Appoints Venkat Ramanan as Chief Financial Officer

10/01 07:00 am

Multiple Modalities in the Oncology Market Size, Regional Growth and Trends

09/30 11:00 am

Fc and Glycoengineered Antibodies Market Report 2025: Antibody Therapeutics Surge with 550+ Clinical Pipeline Molecules - Fc Innovations Leading the Charge

09/23 10:59 am

European Advisory Panel Recommends Two AstraZeneca Drugs For Approval

09/22 02:20 pm

This 12% Dividend Is on Sale as a $30 Bn 'Hidden' Move Sparks Buying Opportunity

09/18 05:47 am

Here Is My Top Stock Pick Among the Weight Loss Industry Leaders

09/16 03:15 am

Biotech Sector May Flip to Market Leader by Year-End

09/15 01:25 pm

2 Healthcare Dividend Stocks to Buy and Hold

09/14 07:15 am